Clinical Study

Evaluation of the Effectiveness of the Iralvex Gel on the Recurrent Aphthous Stomatitis Management

Table 1

Comparison of VAS score for the Iralvex and placebo groups in different days.

GroupVAS mean ± SE
Day 0Day 1Day 3Day 5

Iralvex gel7.00 ± 0.265.15 ± 0.212.20 ± 0.160.85 ± 0.17
Placebo gel7.50 ± 0.296.10 ± 0.253.85 ± 0.242.15 ± 0.22

value0.205<0.01*<0.001*<0.001*

VAS: visual analogue scale.
*Significant association set at 5.0%.
Independent -test.